| 1 |
34167878 | Roxadustat treatment for anemia in peritoneal dialysis patients: A randomized controlled trial. | 2022 Feb |
1 |
| 2 |
33051677 | The efficacy and safety of roxadustat for anemia in patients with chronic kidney disease: a meta-analysis. | 2021 Aug 27 |
1 |
| 3 |
33389461 | The efficacy and safety of roxadustat treatment for anemia in patients with kidney disease: a meta-analysis and systematic review. | 2021 May |
1 |
| 4 |
32309288 | Treatment of Renal Anemia with Roxadustat: Advantages and Achievement. | 2020 Mar |
2 |
| 5 |
31340089 | Roxadustat for Anemia in Patients with Kidney Disease Not Receiving Dialysis. | 2019 Sep 12 |
1 |
| 6 |
26494833 | Roxadustat (FG-4592): Correction of Anemia in Incident Dialysis Patients. | 2016 Apr |
1 |
| 7 |
26846333 | Roxadustat (FG-4592) Versus Epoetin Alfa for Anemia in Patients Receiving Maintenance Hemodialysis: A Phase 2, Randomized, 6- to 19-Week, Open-Label, Active-Comparator, Dose-Ranging, Safety and Exploratory Efficacy Study. | 2016 Jun |
2 |
| 8 |
27094610 | Oral Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor Roxadustat (FG-4592) for the Treatment of Anemia in Patients with CKD. | 2016 Jun 6 |
2 |
| 9 |
26238121 | Randomized placebo-controlled dose-ranging and pharmacodynamics study of roxadustat (FG-4592) to treat anemia in nondialysis-dependent chronic kidney disease (NDD-CKD) patients. | 2015 Oct |
1 |